IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations

09/23/2025 | Press release | Archived content

Adult immunization: A critical investment for health, equity, and economic resilience

Immunization is an effective public health strategy to help prevent and reduce the impact of infectious diseases throughout the life course.

As populations age and non-communicable diseases (NCDs) increase, our societies are becoming more vulnerable to preventable infectious diseases. This can put a significant strain on health systems, societies, and economies.

Vaccines are wide recognized as safe and effective tools against infectious diseases. This is true across the life course. For instance, adult immunization, including the elderly and those living with NCDs, brings immediate and long-term benefits. These benefits extend to wider health systems, societies, and economies.

This two-pager expands on what action is needed to harness the opportunity of adult immunization - from elevating immunization as a public health priority to empowering healthcare professionals for greater access and uptake.

IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on September 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2025 at 08:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]